跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,214 条关于
“VMS+ 4.0”
全部
7,214
临床试验
5,466
药物
959
机构
19
资讯
770
4个月前
Ventripoint's AI-Powered Cardiac Imaging System VMS+ 4.0 Submitted for Expedited Regulatory Approval in China
去年
iCAD's ProFound Detection 4.0 Receives FDA Clearance for Enhanced Breast Cancer Detection
2年前
Astellas' Fezolinetant Enters Phase 3 Trial for VMS in Breast Cancer Patients on Endocrine Therapy
去年
Novel VMS Therapy Shows Early Promise in Improving Quality of Life for Breast Cancer Patients
3个月前
Global Pharma 4.0 Market Projected to Reach USD 90.71 Billion by 2034, Growing at 19.80% CAGR
去年
Bayer's Elinzanetant Shows Promise in Reducing Hot Flashes for Breast Cancer Patients
2年前
FDA Accepts Bayer's Elinzanetant for Review in Menopausal Vasomotor Symptoms
去年
iCad's AI-Powered Breast Cancer Detection Tech ProFound Detection version 4.0 Receives FDA Clearance
去年
Palvella Therapeutics Advances QTORIN™ Rapamycin for Rare Genetic Skin Diseases
去年
Bayer Seeks EU Approval for Elinzanetant to Treat Menopausal Vasomotor Symptoms
第 1 页,共 77 页
上一页
下一页